863680-45-9,MFCD31726290
Catalog No.:AA01FNN4

863680-45-9 | GSK598809

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
99%
1 week  
$368.00   $258.00
- +
10mg
99%
1 week  
$558.00   $391.00
- +
50mg
99%
1 week  
$1,574.00   $1,102.00
- +
100mg
99%
1 week  
$2,489.00   $1,742.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA01FNN4
Chemical Name:
GSK598809
CAS Number:
863680-45-9
Molecular Formula:
C22H23F4N5OS
Molecular Weight:
481.5095
MDL Number:
MFCD31726290
SMILES:
Fc1cc(ccc1C12CN(CC2C1)CCCSc1nnc(n1C)c1ocnc1C)C(F)(F)F
Properties
Computed Properties
 
Complexity:
704  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
33  
Hydrogen Bond Acceptor Count:
10  
Rotatable Bond Count:
7  
Undefined Atom Stereocenter Count:
2  
XLogP3:
4.1  

Literature

Title: High-affinity and selective dopamine D₃ receptor full agonists.

Journal: Bioorganic & medicinal chemistry letters 20120901

Title: 1,2,4-Triazolyl azabicyclo[3.1.0]hexanes: a new series of potent and selective dopamine D(3) receptor antagonists.

Journal: Journal of medicinal chemistry 20100114

Title: Appel NM, et al. Dopamine D3 Receptor Antagonist (GSK598809) Potentiates the Hypertensive Effects of Cocaine in Conscious, Freely-Moving Dogs. J Pharmacol Exp Ther. 2015 Sep;354(3):484-92.

Title: Micheli F, et al. 1,2,4-Triazolyl azabicyclo.1.0hexanes: a new series of potent and selective dopamine D(3) receptor antagonists. J Med Chem. 2010 Jan 14;53(1):374-91.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 863680-45-9
Tags:863680-45-9 Molecular Formula|863680-45-9 MDL|863680-45-9 SMILES|863680-45-9 GSK598809
Catalog No.: AA01FNN4
863680-45-9,MFCD31726290
863680-45-9 | GSK598809
Pack Size: 5mg
Purity: 99%
1 week
$368.00 $258.00
Pack Size: 10mg
Purity: 99%
1 week
$558.00 $391.00
Pack Size: 50mg
Purity: 99%
1 week
$1,574.00 $1,102.00
Pack Size: 100mg
Purity: 99%
1 week
$2,489.00 $1,742.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA01FNN4
Chemical Name: GSK598809
CAS Number: 863680-45-9
Molecular Formula: C22H23F4N5OS
Molecular Weight: 481.5095
MDL Number: MFCD31726290
SMILES: Fc1cc(ccc1C12CN(CC2C1)CCCSc1nnc(n1C)c1ocnc1C)C(F)(F)F
Properties
Complexity: 704  
Covalently-Bonded Unit Count: 1  
Heavy Atom Count: 33  
Hydrogen Bond Acceptor Count: 10  
Rotatable Bond Count: 7  
Undefined Atom Stereocenter Count: 2  
XLogP3: 4.1  
Literature fold

Title: High-affinity and selective dopamine D₃ receptor full agonists.

Journal: Bioorganic & medicinal chemistry letters20120901

Title: 1,2,4-Triazolyl azabicyclo[3.1.0]hexanes: a new series of potent and selective dopamine D(3) receptor antagonists.

Journal: Journal of medicinal chemistry20100114

Title: Appel NM, et al. Dopamine D3 Receptor Antagonist (GSK598809) Potentiates the Hypertensive Effects of Cocaine in Conscious, Freely-Moving Dogs. J Pharmacol Exp Ther. 2015 Sep;354(3):484-92.

Title: Micheli F, et al. 1,2,4-Triazolyl azabicyclo.1.0hexanes: a new series of potent and selective dopamine D(3) receptor antagonists. J Med Chem. 2010 Jan 14;53(1):374-91.

Building Blocks More >
140163-89-9
140163-89-9
Imicyafos
AA01FNWJ
1219805-46-5
1219805-46-5
1,4-Butane-d8-dithiol
AA01FO0G
2088282-58-8
2088282-58-8
(2-Iodoethyl)perfluorocyclohexane
AA01FO3D
1516938-12-7
1516938-12-7
4-{[3-(Trifluoromethyl)phenoxy]methyl}piperidinehydrochloride
AA01FO6P | MFCD09879201
954261-60-0
954261-60-0
N-(4-Aminophenyl)-2-(2-chlorophenoxy)propanamide
AA01FO8W
1865223-60-4
1865223-60-4
4-Cyanobenzohydrazide hydrochloride
AA01FOBB | MFCD30181469
1361114-78-4
1361114-78-4
2-(6-Bromopyridin-2-yl)-4-methylmorpholine hydrochloride
AA01FOEM
878769-10-9
878769-10-9
4-HYDROXY-3-NITROSO-1-NAPHTHALENESULFONIC ACID, SODIUM SALT
AA01FOHV | MFCD00159193
338977-83-6
338977-83-6
2-[(2-chlorobenzyl)sulfanyl]quinoxaline
AA01FOKG
32725-40-9
32725-40-9
3-pyridin-4-yl-1H-pyrazole-5-carbohydrazide
AA01FOO1
Submit
© 2017 AA BLOCKS, INC. All rights reserved.